Paul Newhouse
Paul Newhouse
Vanderbilt University School of Medicince
Verified email at
Cited by
Cited by
Clock drawing in Alzheimer's disease: a novel measure of dementia severity
T Sunderland, JL Hill, AM Mellow, BA Lawlor, J Gundersheimer, ...
Journal of the American Geriatrics society 37 (8), 725-729, 1989
Effects of nicotinic stimulation on cognitive performance
PA Newhouse, A Potter, A Singh
Current opinion in pharmacology 4 (1), 36-46, 2004
Intravenous nicotine in Alzheimer's disease: a pilot study
PA Newhouse, T Sunderland, PN Tariot, CL Blumhardt, H Weingartner, ...
Psychopharmacology 95, 171-175, 1988
Nicotinic system involvement in Alzheimer’s and Parkinson’s diseases: implications for therapeutics
PA Newhouse, A Potter, ED Levin
Drugs & aging 11, 206-228, 1997
Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain
DA Seminowicz, M Shpaner, ML Keaser, GM Krauthamer, J Mantegna, ...
The Journal of Pain 14 (12), 1573-1584, 2013
The effects of nicotine on Parkinson's disease.
MC Kelton, HJ Kahn, CL Conrath, PA Newhouse
Brain and cognition 43 (1-3), 274-282, 2000
Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial
P Newhouse, K Kellar, P Aisen, H White, K Wesnes, E Coderre, A Pfaff, ...
Neurology 78 (2), 91-101, 2012
L-deprenyl in Alzheimer's disease: preliminary evidence for behavioral change with monoamine oxidase B inhibition
PN Tariot, RM Cohen, T Sunderland, PA Newhouse, D Yount, AM Mellow, ...
Archives of general psychiatry 44 (5), 427-433, 1987
A new scale for the assessment of depressed mood in demented patients.
T Sunderland, IS Alterman, D Yount, JL Hill, PN Tariot, PA Newhouse, ...
The American journal of psychiatry 145 (8), 955-959, 1988
The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation
JA Dumas, PA Newhouse
Pharmacology Biochemistry and Behavior 99 (2), 254-261, 2011
Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder
AS Potter, PA Newhouse
Psychopharmacology 176, 183-194, 2004
Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle
K Albert, J Pruessner, P Newhouse
Psychoneuroendocrinology 59, 14-24, 2015
A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients
PA Newhouse, KRR Krishnan, PM Doraiswamy, EM Richter, ED Batzar, ...
Journal of Clinical Psychiatry 61 (8), 559-568, 2000
Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments
JN Vega, PA Newhouse
Current psychiatry reports 16, 1-11, 2014
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression
LS Schneider, JC Nelson, CM Clary, P Newhouse, KRR Krishnan, ...
American Journal of Psychiatry 160 (7), 1277-1285, 2003
Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease
A Potter, J Corwin, J Lang, M Piasecki, R Lenox, PA Newhouse
Psychopharmacology 142, 334-342, 1999
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder
AS Potter, PA Newhouse
Pharmacology Biochemistry and Behavior 88 (4), 407-417, 2008
Acute nicotinic blockade produces cognitive impairment in normal humans
PA Newhouse, A Potter, J Corwin, R Lenox
Psychopharmacology 108 (4), 480-484, 1992
Nicotinic treatment of Alzheimer’s disease
PA Newhouse, A Potter, M Kelton, J Corwin
Biological psychiatry 49 (3), 268-278, 2001
DHEA treatment of Alzheimer’s disease: a randomized, double-blind, placebo-controlled study
OM Wolkowitz, JH Kramer, VI Reus, MM Costa, K Yaffe, P Walton, ...
Neurology 60 (7), 1071-1076, 2003
The system can't perform the operation now. Try again later.
Articles 1–20